These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10769438)

  • 1. Transplantation osteoporosis and corticosteroid-induced osteoporosis in autoimmune diseases: experience with alfacalcidol.
    Dequeker J; Borghs H; Van Cleemput J; Nevens F; Verleden G; Nijs J
    Z Rheumatol; 2000; 59 Suppl 1():53-7. PubMed ID: 10769438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Osteoporosis in rheumatoid arthritis--significance of alfacalcidol in prevention and therapy].
    Schacht E
    Z Rheumatol; 2000; 59 Suppl 1():10-20. PubMed ID: 10769429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of alfacalcidol in clinical conditions characterized by high rate of bone loss.
    Reginster JY; Lecart MP; Richy F
    J Rheumatol Suppl; 2005 Sep; 76():21-5. PubMed ID: 16142847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of alendronate on glucocorticoid-induced osteoporosis in Japanese women with systemic autoimmune diseases: versus alfacalcidol.
    Takeda S; Kaneoka H; Saito T
    Mod Rheumatol; 2008; 18(3):271-6. PubMed ID: 18427724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of alfacalcidol on mineral density of bone tissue in patients with rheumatoid arthritis].
    Gukasian DA; Nasonov EL; Balabanova RM; Smirnov AV; Vlasova IS
    Klin Med (Mosk); 2001; 79(9):47-50. PubMed ID: 11641938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etidronate prevents high dose glucocorticoid induced bone loss in premenopausal individuals with systemic autoimmune diseases.
    Nakayamada S; Okada Y; Saito K; Tanaka Y
    J Rheumatol; 2004 Jan; 31(1):163-6. PubMed ID: 14705236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative studies on effect of risedronate and alfacalcidol against glucocorticoid-induced osteoporosis in rheumatoid arthritic patients.
    Yamada S; Takagi H; Tsuchiya H; Nakajima T; Ochiai H; Ichimura A; Iwata H; Toriyama T
    Yakugaku Zasshi; 2007 Sep; 127(9):1491-6. PubMed ID: 17827929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic use of alfacalcidol in corticosteroid-induced osteoporosis.
    Reginster JY; Kuntz D; Verdickt W; Wouters M; Guillevin L; Menkès CJ; Nielsen K
    Osteoporos Int; 1999; 9(1):75-81. PubMed ID: 10367032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale for treatment of involutional osteoporosis in women and for prevention and treatment of corticosteroid-induced osteoporosis with alfacalcidol.
    Schacht E
    Calcif Tissue Int; 1999 Oct; 65(4):317-27. PubMed ID: 10485985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of corticosteroid-induced osteoporosis by alfacalcidol.
    Lakatos P; Nagy Z; Kiss L; Horvath C; Takacs I; Foldes J; Speer G; Bossanyi A
    Z Rheumatol; 2000; 59 Suppl 1():48-52. PubMed ID: 10769437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Questions on the superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis.
    Ringe JD
    Rheumatol Int; 2004 Nov; 24(6):370. PubMed ID: 15490174
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of renal transplant recipients with low bone mineral density: a randomized prospective trial of alendronate, alfacalcidol, and alendronate combined with alfacalcidol.
    Trabulus S; Altiparmak MR; Apaydin S; Serdengecti K; Sariyar M
    Transplant Proc; 2008; 40(1):160-6. PubMed ID: 18261575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis.
    Ringe JD; Faber H; Fahramand P; Schacht E
    J Rheumatol Suppl; 2005 Sep; 76():33-40. PubMed ID: 16142849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis.
    Ringe JD; Dorst A; Faber H; Schacht E; Rahlfs VW
    Rheumatol Int; 2004 Mar; 24(2):63-70. PubMed ID: 14513268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance exercise training restores bone mineral density in heart transplant recipients.
    Braith RW; Mills RM; Welsch MA; Keller JW; Pollock ML
    J Am Coll Cardiol; 1996 Nov; 28(6):1471-7. PubMed ID: 8917260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing bone loss in renal transplant recipients with vitamin D.
    El-Agroudy AE; El-Husseini AA; El-Sayed M; Ghoneim MA
    J Am Soc Nephrol; 2003 Nov; 14(11):2975-9. PubMed ID: 14569109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.
    Richy F; Schacht E; Bruyere O; Ethgen O; Gourlay M; Reginster JY
    Calcif Tissue Int; 2005 Mar; 76(3):176-86. PubMed ID: 15692726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 4-year treatment with once-weekly clodronate on prevention of corticosteroid-induced bone loss and fractures in patients with arthritis: evaluation with dual-energy X-ray absorptiometry and quantitative ultrasound.
    Frediani B; Falsetti P; Baldi F; Acciai C; Filippou G; Marcolongo R
    Bone; 2003 Oct; 33(4):575-81. PubMed ID: 14555261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial: comparison of alendronate and alfacalcidol in glucocorticoid-associated osteoporosis in patients with ulcerative colitis.
    Kitazaki S; Mitsuyama K; Masuda J; Harada K; Yamasaki H; Kuwaki K; Takedatsu H; Sugiyama G; Tsuruta O; Sata M
    Aliment Pharmacol Ther; 2009 Feb; 29(4):424-30. PubMed ID: 19035979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of calcium and alfacalcidol supplement in the prevention of osteopenia after kidney transplantation.
    Berczi C; Asztalos L; Kincses Z; Balogh A; Löcsey L; Balázs G; Lukács G
    Osteoporos Int; 2003 Jun; 14(5):412-7. PubMed ID: 12730763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.